Advertisement
Screener

GAIN THERAPEUTICS, INC (GANX) Net Margin

GAIN THERAPEUTICS, INC (GANX) Net Margin

  • 2023-03-31: Net Margin -9310.11%.
  • 2022-06-30: Net Margin -5347.33%.
  • 2022-03-31: Net Margin -8718.21%.
  • 2021-12-31: Net Margin -8860.33%.

Complete source-backed net margin history.

Available history
2020-03-31 to 2023-12-31
Data captured

Historical Net Margin

DateNet Margin
2023-03-31-9310.11%
2022-06-30-5347.33%
2022-03-31-8718.21%
2021-12-31-8860.33%
2021-09-30-29200.01%
2021-06-30-4357.78%
2021-03-31-46506.87%
2020-12-31-18116.65%
2020-09-30-11863.37%
2020-06-30-8526.00%
2020-03-31-8755.70%

Annual Net Margin

DateNet Margin
2023-12-31-40354.33%
2022-12-31-13262.02%
2021-12-31-10371.70%
2020-12-31-12387.67%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B